.Atea Pharmaceuticals' antiviral has actually fallen short yet another COVID-19 trial, yet the biote...
.Neurocrine Biosciences' schizophrenia course pivot has actually stopped working. The biotech was un...
.Sanofi has brought in an overdue entry to the radioligand event, paying one hundred million europea...
.After F2G's first attempt to obtain a brand-new class of antifungal to market was actually wrecked ...
.Moderna has actually promised to cut R&D investing by $1.1 billion through 2027. The selection t...
.Just four months after Sanofi bet $80 million in upfront money on Key Rehabs' losmapimod, the progr...
.Cancer cells business Oncternal Therapeutics is folding all its own scientific tests and giving up ...
.Roche is actually keeping out chances that its own injectable being overweight possibility could ul...
.Novo Nordisk has raised the cover on a stage 1 trial of its dental amylin as well as GLP-1 receptor...
.Merely a handful of brief weeks after gaining an FDA Fast Track tag for its own investigational BTK...